The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease

Annals of the New York Academy of Sciences

Volumn 1190, Issue , 2010, Pages 151-158

  Fujimoto, Makoto ^a   Tsuneyama, Koichi ^a   Kinoshita, Hideki ^b   Goto, Hirozo ^a   Takano, Yasuo ^a   Selmi, Carlo ^c,d   Keen, Carl L ^e   Gershwin, M Eric ^c   Shimada, Yutaka ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Kinoshita Internal Medicine Clinic   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Liver steatosis; Metabolic syndrome; Steatohepatitis; Traditional Japanese medicine

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; KEISHI BUKURYO GAN;

ADULT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SAFETY; ECHOGRAPHY; FEMALE; HEPATITIS; HUMAN; LABORATORY TEST; LIVER INJURY; MALE; NONALCOHOLIC FATTY LIVER; OUTPATIENT CARE; PRESCRIPTION; RETROSPECTIVE STUDY; TRADITIONAL MEDICINE; TREATMENT OUTCOME;

ANIMALIA;

EID: 77950257025     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05265.x     Document Type: Conference Paper

References (33)

1. Farrell, G.C.&C.Z. Larter. 2006.Nonalcoholic fatty liver disease: fromsteatosis to cirrhosis.Hepatology Baltimore, Md. 43: S99-S112.
2. Chitturi, S. et al. 2002. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology Baltimore, Md. 35: 373-379.
3. Pagano, G. et al. 2002. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology Baltimore, Md. 35: 367-372.
4. Nakanishi, Y. et al. 2008. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J. Autoimmun. 30: 42-50.
5. Adams, L.A. et al. 2005. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121.
6. Portincasa, P. et al. 2005. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin. Biochem. 38: 203-217.
7. Selmi, C. et al. 2007. Non-alcoholic fatty liver disease: the new epidemic and the need for novel nutritional approaches. J. Med. Food. 10: 563-565.
8. Sekiya, N. et al. 1999. Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit. Phytother. Res. 13: 192-196.
9. Itoh, T. et al. 1988. Effects of Keishi-bukuryo-gan on the microcirculation of bulbar conjunctiva in normal subfects. J. Med. Pharm. Soc. WAKAN-YAKU. 5: 206-210.
10. Terasawa,K. 1993.Kampo (Japanese-OrientalMedicine)- Insights from Clinical Cases K.K. Standard McIntyre., Tokyo.
11. Fujimoto, M. et al. 2008. Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver. Exp. Biol. Med. Maywood, N.J. 233: 328-337.
12. Torres, D.M. & S.A. Harrison. 2008. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology. 134: 1682-1698.
13. Knowler,W.C. et al. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346: 393-403.
14. Mackay, I.R., N.V. Leskovsek & N.R. Rose. 2008. Cell damage and autoimmunity: a critical appraisal. J. Autoimm. 30: 5-11.
15. Lleo, A. et al. 2008. The consequences of apoptosis in autoimmunity. J. Autoimm. 31: 257-262.
16. Kobayashi, H. et al. 2004. Diet and Japanese herbal medicine for recalcitrant atopic dermatitis: efficacy and safety. Drug. Exp.Clin. Res. 30: 197-202.
17. Kainuma, M. et al. 2006. Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulinresistant fatty liver disease with characteristic fibrosis. J. Gastroenterol. 41: 971-980.
18. Day, C.P. & O.F. James. 1998. Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
19. Grattagliano, I. et al. 2003. Adaptation of subcellular glutathione detoxification system to stress conditions in choline-deficient diet induced rat fatty liver. Cell Biol. Toxicol. 19: 355-366.
20. Kirsch,R. et al. 2006.Rodent nutritionalmodel of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. J. Gastroenterol. Hepatol. 21: 174-182.
21. Chitturi, S. et al. 2002. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology Baltimore, Md. 36: 403-409.
22. Seifalian, A.M. et al. 1998. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl. Surg. 4: 71-77.
23. Seifalian, A.M. et al. 1999. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 68: 780-784.
24. Caraceni, P. et al. 1999. Ischemia-reperfusion injury in rat fatty liver: role of nutritional status. Hepatology Baltimore, Md. 29: 1139-1146.
25. McCuskey, R.S. et al. 2004. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology Baltimore, Md. 40: 386-393.
26. Hasegawa, T. et al. 2007. Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice. Am. J.Physiol. 292: G1385-G1395.
27. Tosa, H., K. Toriizuka & K. Terasawa. 1987. The effect of Keishi-bukuryo-gan on blood viscosity and blood coagulation in normal subjects. J.Med. Pharm. Soc.WAKANYAKU. 4: 172-179.
28. Kohta, K. et al. 1993. Effects of Keishi-bukuryo-gan on erythrocyte aggregability in patients with multiple old lacunar infarction. J. Med. Pharm. Soc. WAKAN-YAKU. 10: 251-259.
29. Sekiya, N. et al. 2002. Keishi-bukuryo-gan preserves the endothelium dependent relaxation of thoracic aorta in cholesterol-fed rabbit by limiting superoxide generation. Phytother. Res. 16: 524-528.
30. Goto, H. et al. 2004. Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats. Phytomedicine 11: 188-195.
31. Goto, H. et al. 1996. Endothelium-dependent vasodilator effect of extract prepared from the roots of Paeonia lactiflora on isolated rat aorta. Planta Medica 62: 436-439.
32. Tanikawa, K. et al. 1999. Endothelium-dependent vasodilator effect of tannin extract from Cinnamonomi cortex on isolated rat aorta. J. Trad. Med. 16: 45-50.
33. Deane, S., F.J.Meyers&M.E. Gershwin. 2008. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J. Autoimm. 30: 180-196.